fluoxetine has been researched along with meglumine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cao, Y; Lester, HA; Mager, S | 1 |
| Pache, DM; Sewell, RD; Subhan, F | 1 |
3 other study(ies) available for fluoxetine and meglumine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
H+ permeation and pH regulation at a mammalian serotonin transporter.
Topics: Animals; Carrier Proteins; Desipramine; Female; Fluoxetine; Glycine; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Meglumine; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Nerve Tissue Proteins; Oocytes; Patch-Clamp Techniques; Protons; Rats; Recombinant Proteins; RNA, Complementary; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sodium; Time Factors; Transcription, Genetic; Xenopus laevis | 1997 |
Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetine.
Topics: Alanine; Animals; Conditioning, Operant; Disulfides; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Indoles; Male; Meglumine; Narcotics; Protease Inhibitors; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors | 2000 |